Synth-Med
synth-med.com
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
Horizons Ventures
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Horizons Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Generating a chemical atlas for treating human disease. Our ATLAS technology merges AcTive® Learning with Automated Synthesis and…
ImpriMed uses live-cell testing and AI to predict drug response for veterinary oncology, human blood cancers, and pharma drug development…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Our next-generation health monitor unlocks an ongoing dialogue between you and your body. Similar to blood, saliva can be used to track…
BioSapien's MediChip™ delivers sustained cancer therapy directly at the tumor site while minimizing systemic exposure through localized…
Endogene.bio generates high-resolution data from menstrual blood to accelerate disease understanding, patient stratification, and…
Overview
We deliver medicine to the once-unreachable corners of the human body. Drugs are hard to reach brain and tumors due to blood brain barrier and barriers around the tumors. We use smart human blood to transport drugs directly to disease sites.
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Toronto
Canada
HQ
661 University Ave, Toronto, ON, Canada
661 University Avenue, Suite 1300, Toronto, Ontario, Canada M5G 0B7